Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Phathom Pharmaceuticals To Present Voquezna® Data At The American College Of Gastroenterology Acg 2024 Annual Meeting is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Phathom Pharmaceuticals Announces FDA Approval of Citizen Petition Confirming 10-Year Exclusivity for VOQUEZNA®
Phathom Pharmaceuticals, Inc. announced that the FDA has approved its Citizen Petition, recognizing 10 years of New Chemical Entity exclusivity for its medication VOQUEZNA® (vonoprazan) tablets, which ... Read More
Phathom Pharmaceuticals Announces FDA Update Confirming 10-Year Non-Patent Exclusivity for VOQUEZNA®
Phathom Pharmaceuticals, Inc. announced that the FDA has updated the Orange Book to reflect a full 10-year period of non-patent exclusivity for their medication VOQUEZNA® (vonoprazan) in both 10 mg ... Read More
Phathom Pharmaceuticals Announces FDA Correction to Orange Book Listing, Confirming 10 Years of Regulatory Exclusivity for VOQUEZNA® (vonoprazan) Tablets Through May 3, 2032
FLORHAM PARK, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus